American Association for Cancer Research

PCWG at the Annual Meeting 2013

Annual Meeting 2013

AACR Pediatric Cancer Working Group Town Hall Meeting and Reception

Sunday, April 7, 2013, 7:00 p.m. – 9:00 p.m.
Renaissance Hotel, Grand Ballroom South

Session description: Members of the Pediatric Cancer Working Group (PCWG) and those interested in pediatric oncology were invited to attend this special evening session. Meeting consisted of a summary of AACR’s pediatric-cancer related programs and activities, an open discussion, and networking reception. 

Speaker/Moderator
Lee J. Helman, National Cancer Institute, Bethesda, MD

AACR Pediatric Cancer Working Group Special Session

"From Biology to New Targets in High-Risk Childhood Cancers"

Tuesday, April 9, 2013, 8:15 a.m. – 10:15 a.m.
Walter E. Washington Convention Center, East Hall, Salon C

Session description: All meeting attendees were invited to attend this special PCWG-sponsored event showcasing cutting-edge pediatric cancer-based research. Session consisted of four talks followed by a panel discussion involving all speakers.

Chairperson
Lee J. Helman, National Cancer Institute, Bethesda, MD

Speakers/Panelists

A. Thomas Look. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
• "KPT-SINE, a novel drug that inhibits nuclear transport and has pronounced activity against human leukemia while sparing normal hematopoietic cells"
Jan J. Molenaar. University of Amsterdam, The Netherlands
• “MYCN signaling and new therapeutic options in neuroblastoma”
Charles W.M. Roberts. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
• “SWI/SNF complex mutations in pediatric cancers”
Poul H.B. Sorensen. BC Cancer Research Centre, University of British Columbia, Vancouver, BC, Canada
• "Acute changes in the protein translatome protect high-risk childhood cancer cells from stress and therapy"

Other Pediatric Oncology Related Events at the Annual Meeting 2013:

Current Concepts in Organ Site Research Session-"Pediatric Cancer: From Susceptibility to Targeted Therapies"

Minisymposium Session-"Pediatric Cancer 1: Genomic Landscapes, Microenvironment, and Response to Therapy"

NCI/NIH-Sponsored Session-"TARGETing Better Treatments for Childhood Cancers: A Progress Report on the NCI’s Therapeutically Applicable Research to Generate Effective Treatments Initiative"

Poster Sessions
-"Preclinical Evaluation of Candidate Therapies for Pediatric Cancer"
-"Genetics, Genomics, Epigenetics, and Biomarkers of Pediatric Cancer"
-"Pediatric Cancer 2: New Targets, Developmental Pathways, and Animal Models"